Association between dispensing of low-value oral albuterol and removal from Medicaid preferred drug lists

BACKGROUND: Oral albuterol has worse efficacy and side effects compared with inhaled albuterol, and thus its use has been discouraged for decades. Drug inclusion or exclusion on formularies have been associated with reductions in low-value care. This study examines dispensing of oral albuterol and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Volerman, Anna, Pelczar, Alison, Conti, Rena, Ciaccio, Christina, Chua, Kao-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044602/
https://www.ncbi.nlm.nih.gov/pubmed/35473608
http://dx.doi.org/10.1186/s12913-022-07955-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044602/
https://www.ncbi.nlm.nih.gov/pubmed/35473608
http://dx.doi.org/10.1186/s12913-022-07955-x

Ejemplares similares